Does the media favor QDEL or MMSI?

In the previous week, QuidelOrtho and QuidelOrtho both had 5 articles in the media. Merit Medical Systems' average media sentiment score of 1.17 beat QuidelOrtho's score of 0.33 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Merit Medical Systems 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor QDEL or ICUI?

In the previous week, QuidelOrtho and QuidelOrtho both had 5 articles in the media. ICU Medical's average media sentiment score of 0.64 beat QuidelOrtho's score of 0.33 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral ICU Medical 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor QDEL or HAE?

In the previous week, QuidelOrtho had 4 more articles in the media than Haemonetics. MarketBeat recorded 5 mentions for QuidelOrtho and 1 mentions for Haemonetics. QuidelOrtho's average media sentiment score of 0.33 beat Haemonetics' score of 0.00 indicating that QuidelOrtho is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Haemonetics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor QDEL or XRAY?

In the previous week, QuidelOrtho and QuidelOrtho both had 5 articles in the media. DENTSPLY SIRONA's average media sentiment score of 1.04 beat QuidelOrtho's score of 0.33 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral DENTSPLY SIRONA 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is QDEL or NEOG more profitable?

QuidelOrtho has a net margin of -45.57% compared to Neogen's net margin of -69.93%. QuidelOrtho's return on equity of 4.25% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets QuidelOrtho -45.57% 4.25% 1.56% Neogen -69.93% 2.35% 1.46%

Does the media prefer QDEL or NEOG?

In the previous week, QuidelOrtho and QuidelOrtho both had 5 articles in the media. Neogen's average media sentiment score of 0.47 beat QuidelOrtho's score of 0.33 indicating that Neogen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Neogen 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

QuidelOrtho (QDEL) Competitors

$17.66 -0.23 (-1.29%)

Closing price 07/14/2026 04:00 PM Eastern

Extended Trading

$17.66 0.00 (-0.03%)

As of 07/14/2026 04:10 PM Eastern

Compare

QDEL vs. MMSI, ICUI, HAE, XRAY, and NEOG

Should you buy QuidelOrtho stock or one of its competitors? MarketBeat compares QuidelOrtho with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with QuidelOrtho include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), and Neogen (NEOG). These companies are all part of the "health care supplies" industry.

How does QuidelOrtho compare to Merit Medical Systems?

QuidelOrtho (NASDAQ:QDEL) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 1.1% of QuidelOrtho shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, QuidelOrtho and QuidelOrtho both had 5 articles in the media. Merit Medical Systems' average media sentiment score of 1.17 beat QuidelOrtho's score of 0.33 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Merit Medical Systems	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

QuidelOrtho has a beta of 0.69, suggesting that its share price is 31% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

QuidelOrtho currently has a consensus price target of $13.63, suggesting a potential downside of 22.85%. Merit Medical Systems has a consensus price target of $92.80, suggesting a potential upside of 30.67%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

Merit Medical Systems has lower revenue, but higher earnings than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.44	-$1.13B	-$17.82	N/A
Merit Medical Systems	$1.54B	2.75	$128.49M	$2.31	30.74

Merit Medical Systems has a net margin of 9.03% compared to QuidelOrtho's net margin of -45.57%. Merit Medical Systems' return on equity of 13.54% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-45.57%	4.25%	1.56%
Merit Medical Systems	9.03%	13.54%	7.94%

Summary

Merit Medical Systems beats QuidelOrtho on 12 of the 15 factors compared between the two stocks.

How does QuidelOrtho compare to ICU Medical?

QuidelOrtho (NASDAQ:QDEL) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

QuidelOrtho currently has a consensus price target of $13.63, indicating a potential downside of 22.85%. ICU Medical has a consensus price target of $168.40, indicating a potential upside of 9.71%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
ICU Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	3 Strong Buy rating(s)	3.00

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 1.1% of QuidelOrtho shares are held by insiders. Comparatively, 2.1% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

ICU Medical has a net margin of 2.15% compared to QuidelOrtho's net margin of -45.57%. ICU Medical's return on equity of 7.50% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-45.57%	4.25%	1.56%
ICU Medical	2.15%	7.50%	3.91%

QuidelOrtho has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

In the previous week, QuidelOrtho and QuidelOrtho both had 5 articles in the media. ICU Medical's average media sentiment score of 0.64 beat QuidelOrtho's score of 0.33 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
ICU Medical	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ICU Medical has lower revenue, but higher earnings than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.44	-$1.13B	-$17.82	N/A
ICU Medical	$2.23B	1.72	$730K	$1.85	82.97

Summary

ICU Medical beats QuidelOrtho on 14 of the 16 factors compared between the two stocks.

How does QuidelOrtho compare to Haemonetics?

QuidelOrtho (NASDAQ:QDEL) and Haemonetics (NYSE:HAE) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 1.1% of QuidelOrtho shares are held by insiders. Comparatively, 2.1% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

QuidelOrtho presently has a consensus target price of $13.63, indicating a potential downside of 22.85%. Haemonetics has a consensus target price of $78.33, indicating a potential upside of 5.26%. Given Haemonetics' stronger consensus rating and higher possible upside, analysts clearly believe Haemonetics is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Haemonetics has lower revenue, but higher earnings than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.44	-$1.13B	-$17.82	N/A
Haemonetics	$1.33B	2.54	$97.31M	$2.02	36.84

QuidelOrtho has a beta of 0.69, indicating that its share price is 31% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

Haemonetics has a net margin of 7.29% compared to QuidelOrtho's net margin of -45.57%. Haemonetics' return on equity of 27.30% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-45.57%	4.25%	1.56%
Haemonetics	7.29%	27.30%	9.59%

In the previous week, QuidelOrtho had 4 more articles in the media than Haemonetics. MarketBeat recorded 5 mentions for QuidelOrtho and 1 mentions for Haemonetics. QuidelOrtho's average media sentiment score of 0.33 beat Haemonetics' score of 0.00 indicating that QuidelOrtho is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Haemonetics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Haemonetics beats QuidelOrtho on 13 of the 17 factors compared between the two stocks.

How does QuidelOrtho compare to DENTSPLY SIRONA?

QuidelOrtho (NASDAQ:QDEL) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

QuidelOrtho currently has a consensus price target of $13.63, suggesting a potential downside of 22.85%. DENTSPLY SIRONA has a consensus price target of $13.42, suggesting a potential upside of 5.64%. Given DENTSPLY SIRONA's stronger consensus rating and higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, QuidelOrtho and QuidelOrtho both had 5 articles in the media. DENTSPLY SIRONA's average media sentiment score of 1.04 beat QuidelOrtho's score of 0.33 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA has a net margin of -17.06% compared to QuidelOrtho's net margin of -45.57%. DENTSPLY SIRONA's return on equity of 18.83% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-45.57%	4.25%	1.56%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

DENTSPLY SIRONA has higher revenue and earnings than QuidelOrtho. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.44	-$1.13B	-$17.82	N/A
DENTSPLY SIRONA	$3.68B	0.69	-$598M	-$3.15	N/A

99.0% of QuidelOrtho shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 1.1% of QuidelOrtho shares are owned by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

QuidelOrtho has a beta of 0.69, suggesting that its share price is 31% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market.

Summary

DENTSPLY SIRONA beats QuidelOrtho on 12 of the 15 factors compared between the two stocks.

How does QuidelOrtho compare to Neogen?

QuidelOrtho (NASDAQ:QDEL) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 1.1% of QuidelOrtho shares are held by company insiders. Comparatively, 0.6% of Neogen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, QuidelOrtho and QuidelOrtho both had 5 articles in the media. Neogen's average media sentiment score of 0.47 beat QuidelOrtho's score of 0.33 indicating that Neogen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Neogen	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

QuidelOrtho has a beta of 0.69, indicating that its stock price is 31% less volatile than the broader market. Comparatively, Neogen has a beta of 1.8, indicating that its stock price is 80% more volatile than the broader market.

QuidelOrtho currently has a consensus target price of $13.63, suggesting a potential downside of 22.85%. Neogen has a consensus target price of $10.67, suggesting a potential upside of 10.31%. Given Neogen's stronger consensus rating and higher possible upside, analysts plainly believe Neogen is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Neogen	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

QuidelOrtho has a net margin of -45.57% compared to Neogen's net margin of -69.93%. QuidelOrtho's return on equity of 4.25% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-45.57%	4.25%	1.56%
Neogen	-69.93%	2.35%	1.46%

Neogen has lower revenue, but higher earnings than QuidelOrtho. Neogen is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.44	-$1.13B	-$17.82	N/A
Neogen	$894.66M	2.35	-$1.09B	-$2.80	N/A

Summary

Neogen beats QuidelOrtho on 8 of the 15 factors compared between the two stocks.

Get QuidelOrtho News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QDEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QDEL vs. The Competition

Export

Metric	QuidelOrtho	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.22B	$8.67B	$6.86B	$12.44B
Dividend Yield	N/A	2.55%	2.68%	8.42%
P/E Ratio	-0.99	15.65	27.01	24.38
Price / Sales	0.44	6.52	522.34	91.89
Price / Cash	0.94	18.09	48.59	59.36
Price / Book	0.62	3.56	10.80	6.33
Net Income	-$1.13B	$228.19M	$3.59B	$331.02M
7 Day Performance	2.38%	-1.41%	-1.49%	-0.33%
1 Month Performance	21.21%	-2.08%	2.79%	-1.29%
1 Year Performance	-36.82%	2.26%	28.56%	21.30%

QuidelOrtho Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QDEL QuidelOrtho	2.0655 of 5 stars	$17.66 -1.3%	$13.63 -22.8%	-38.8%	$1.22B	$2.73B	N/A	6,500
MMSI Merit Medical Systems	4.2852 of 5 stars	$73.26 -0.2%	$92.80 +26.7%	-24.0%	$4.38B	$1.52B	31.71	7,500	News Coverage Positive News
ICUI ICU Medical	3.1816 of 5 stars	$157.60 +2.1%	$168.40 +6.9%	+17.3%	$3.86B	$2.23B	85.19	13,000	News Coverage
HAE Haemonetics	1.95 of 5 stars	$76.96 +1.0%	$78.33 +1.8%	-2.8%	$3.46B	$1.33B	38.10	3,009
XRAY DENTSPLY SIRONA	3.9068 of 5 stars	$12.78 +4.2%	$13.42 +5.0%	-20.6%	$2.46B	$3.68B	N/A	14,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QDEL) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QuidelOrtho (QDEL) Competitors

QDEL vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does QuidelOrtho compare to Merit Medical Systems?

Summary

How does QuidelOrtho compare to ICU Medical?

Summary

How does QuidelOrtho compare to Haemonetics?

Summary

How does QuidelOrtho compare to DENTSPLY SIRONA?

Summary

How does QuidelOrtho compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QDEL vs. The Competition

QuidelOrtho Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QuidelOrtho (QDEL) Competitors

QDEL vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does QuidelOrtho compare to Merit Medical Systems?

Do insiders and institutionals hold more shares of QDEL or MMSI?

Does the media favor QDEL or MMSI?

Which has more volatility and risk, QDEL or MMSI?

Do analysts rate QDEL or MMSI?

Which has preferable earnings & valuation, QDEL or MMSI?

Is QDEL or MMSI more profitable?

Summary

How does QuidelOrtho compare to ICU Medical?

Do analysts prefer QDEL or ICUI?

Do insiders & institutionals believe in QDEL or ICUI?

Is QDEL or ICUI more profitable?

Which has more risk and volatility, QDEL or ICUI?

Does the media favor QDEL or ICUI?

Which has higher earnings & valuation, QDEL or ICUI?

Summary

How does QuidelOrtho compare to Haemonetics?

Do institutionals and insiders believe in QDEL or HAE?

Do analysts prefer QDEL or HAE?

Which has higher valuation and earnings, QDEL or HAE?

Which has more risk and volatility, QDEL or HAE?

Is QDEL or HAE more profitable?

Does the media favor QDEL or HAE?

Summary

How does QuidelOrtho compare to DENTSPLY SIRONA?

Do analysts recommend QDEL or XRAY?

Does the media favor QDEL or XRAY?

Is QDEL or XRAY more profitable?

Which has stronger earnings and valuation, QDEL or XRAY?

Do institutionals and insiders hold more shares of QDEL or XRAY?

Which has more volatility and risk, QDEL or XRAY?

Summary

How does QuidelOrtho compare to Neogen?

Do insiders and institutionals have more ownership in QDEL or NEOG?

Does the media prefer QDEL or NEOG?

Which has more risk & volatility, QDEL or NEOG?

Do analysts prefer QDEL or NEOG?

Is QDEL or NEOG more profitable?

Which has better earnings & valuation, QDEL or NEOG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QDEL vs. The Competition

QuidelOrtho Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools